Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02329548 · ClinicalTrials.gov registry record · NA

Qualitative Sweat Distribution During Tilt Table Procedure

A NA study of Anxiety and Postural Tachycardia Syndrome, sponsored by Nationwide Children's Hospital.

Completed
Registry status
NA
Development phase
95
Enrollment target
1
Study location

NCT02329548: Completed NA study of Anxiety and Postural Tachycardia Syndrome, sponsored by Nationwide Children's Hospital.

NCT02329548 is a NA study of Anxiety and Postural Tachycardia Syndrome that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 95 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02329548, a NA study of Anxiety and Postural Tachycardia Syndrome, has completed, sponsored by Nationwide Children's Hospital.

COMPLETED
Registry status
NA
Development phase
95 participants
Enrollment target
1
Study location

Study Summary

This study uses an Alizarin Red powder mixture to characterize the sweat distributions in youth during tilt table testing. Patients with a known orthostatic sweat response from a prior clinical tilt table test in the investigators laboratory will be recruited. The Alizarin Red powder will be applied to exposed skin, and quantitative sweat will be measured at the thigh. During tilt testing, serial photos will be taken once the sweat response occurs. Sweat distributions will be compared during syncope (orthostatic sweat), during periods of anxiety (emotional sweat), and in patients with POTS (with and without syncope).

Primary Outcome

The temporal and regional sweat distributions will be assessed by serial photography. Orthostatic sweat will be distinguished from emotional sweat based on the presence of hypotension/syncope, self-report of anxiety, and presence of tachypnea (emotional sweat).

Interventions

  • OTHER Alizarin Red

Study Locations (1)

Ohio

  • Nationwide Children's Hospital, neurology outpatient clinic - Columbus

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2014-12
Est. Completion 2016-12
Phase NA
Nationwide Children's Hospital

188 total trials

What the finished NCT02329548 record still lists

NCT02329548 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (78% lower).

The record links to 3 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Alizarin Red is the first listed.

NCT02329548 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT02329548 about?

NCT02329548 is a clinical study titled "Qualitative Sweat Distribution During Tilt Table Procedure". This study uses an Alizarin Red powder mixture to characterize the sweat distributions in youth during tilt table testing. Patients with a known orthostatic sweat response from a prior clinical tilt table test in the investigators laboratory will be recruited. The Alizarin Red powder will be applied...

What is the current status of trial NCT02329548?

This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2014-12. Estimated completion is 2016-12.

What conditions does trial NCT02329548 study?

This clinical trial studies the following conditions: Anxiety, Postural Tachycardia Syndrome, Syncope.

What interventions are being tested in trial NCT02329548?

The interventions under investigation include: Alizarin Red (OTHER).

Who is sponsoring clinical trial NCT02329548?

This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02329548 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02329548's enrollment target sits among peer trials

95 181st of 364 higher than 182 of 364 other Anxiety trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03339128 · 95 participants · Phase 2

    Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children

  • NCT03509961 · 95 participants · Phase 2

    The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

  • NCT03694756 · 95 participants · NA

    TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer

  • NCT04206215 · 95 participants · NA

    Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02329548, the US trial registry maintained by the National Library of Medicine. NCT02329548 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.